AT393625B - Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten - Google Patents

Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten Download PDF

Info

Publication number
AT393625B
AT393625B AT0133784A AT133784A AT393625B AT 393625 B AT393625 B AT 393625B AT 0133784 A AT0133784 A AT 0133784A AT 133784 A AT133784 A AT 133784A AT 393625 B AT393625 B AT 393625B
Authority
AT
Austria
Prior art keywords
dergocrine
pharmaceutically acceptable
preparation
pharmaceutical preparation
alkyl
Prior art date
Application number
AT0133784A
Other languages
German (de)
English (en)
Other versions
ATA133784A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA133784A publication Critical patent/ATA133784A/de
Application granted granted Critical
Publication of AT393625B publication Critical patent/AT393625B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0133784A 1983-04-22 1984-04-20 Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten AT393625B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3314607 1983-04-22

Publications (2)

Publication Number Publication Date
ATA133784A ATA133784A (de) 1991-05-15
AT393625B true AT393625B (de) 1991-11-25

Family

ID=6197070

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0133784A AT393625B (de) 1983-04-22 1984-04-20 Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten

Country Status (27)

Country Link
US (2) US4617306A (en])
JP (1) JPS59205318A (en])
AT (1) AT393625B (en])
AU (1) AU571218B2 (en])
BE (1) BE899434A (en])
CA (1) CA1218932A (en])
CH (1) CH658992A5 (en])
CY (1) CY1499A (en])
DD (1) DD217712A5 (en])
DK (1) DK165965C (en])
FR (1) FR2544614B1 (en])
GB (1) GB2138678B (en])
GR (1) GR81973B (en])
HK (1) HK100289A (en])
HU (1) HU192050B (en])
IE (1) IE57468B1 (en])
IL (1) IL71601A (en])
IT (1) IT1199114B (en])
LU (1) LU85331A1 (en])
MY (1) MY100397A (en])
NL (1) NL188891C (en])
NZ (1) NZ207917A (en])
PH (1) PH20922A (en])
PT (1) PT78455B (en])
SE (1) SE465751B (en])
SG (1) SG53889G (en])
ZA (1) ZA842993B (en])

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3580384D1 (de) * 1984-04-09 1990-12-13 Toyo Boseki Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
ES2306646T3 (es) * 1999-02-09 2008-11-16 Pfizer Products Inc. Composiciones de farmacos basicos con biodisponibilidad incrementada.
US6209563B1 (en) 2000-01-07 2001-04-03 Saturn Electronics & Engineering, Inc. Solenoid control valve
US6321767B1 (en) 2000-01-10 2001-11-27 Saturn Electronics & Engineering, Inc. High flow solenoid control valve
US6581634B2 (en) 2000-01-10 2003-06-24 Saturn Electronics & Engineering, Inc. Solenoid control valve with particle gettering magnet
US20090166274A1 (en) * 2007-05-24 2009-07-02 Eaton Corporation Engine valve with a combined engine oil filter and valve actuator solenoid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1180120A (en) * 1966-06-24 1970-02-04 Sandoz Ltd Pharmaceutical Compositions Containing Alkaloids.
GB1228618A (en]) * 1967-08-17 1971-04-15

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154606C (da) * 1975-05-31 1989-05-01 Sandoz Ag Fremgangsmaade til fremstilling af en stabil oploesning af et hydrogeneret meldroejealkaloid
JPS5487177A (en) * 1977-12-23 1979-07-11 Fujitsu Ltd Component positioning unit
CH642259A5 (de) * 1978-12-21 1984-04-13 Sandoz Ag Galenische zubereitungen fuer orale applikation von ergotalkaloiden.
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen
GB2063670A (en) * 1979-11-28 1981-06-10 Sandoz Products Ltd Ergots and their use in treating minimal brain dysfunction

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1180120A (en) * 1966-06-24 1970-02-04 Sandoz Ltd Pharmaceutical Compositions Containing Alkaloids.
GB1228618A (en]) * 1967-08-17 1971-04-15

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AUSTRIA CODEX 1981/82, OSTERREICHISCHER APOTHEKER-VERLAG WIEN, 1981, SEITEN 15, 140, 247, 360, 766, 767, 912 *

Also Published As

Publication number Publication date
JPH0564124B2 (en]) 1993-09-14
US4797404A (en) 1989-01-10
NL188891C (nl) 1992-11-02
CA1218932A (en) 1987-03-10
GB2138678A (en) 1984-10-31
NL8401155A (nl) 1984-11-16
JPS59205318A (ja) 1984-11-20
GB2138678B (en) 1986-11-05
ATA133784A (de) 1991-05-15
PT78455A (en) 1984-05-01
AU571218B2 (en) 1988-04-14
DK201884A (da) 1984-10-23
DK201884D0 (da) 1984-04-18
FR2544614A1 (fr) 1984-10-26
IE840977L (en) 1984-10-22
IT8448082A0 (it) 1984-04-20
CY1499A (en) 1990-08-03
AU2712084A (en) 1984-10-25
SE8402199D0 (sv) 1984-04-19
IT1199114B (it) 1988-12-30
SE8402199L (sv) 1984-10-23
HUT37889A (en) 1986-03-28
SE465751B (sv) 1991-10-28
ZA842993B (en) 1985-11-27
IE57468B1 (en) 1993-01-27
DD217712A5 (de) 1985-01-23
IL71601A (en) 1988-12-30
FR2544614B1 (fr) 1987-08-21
LU85331A1 (fr) 1984-11-28
CH658992A5 (de) 1986-12-31
IL71601A0 (en) 1984-07-31
BE899434A (fr) 1984-10-16
HK100289A (en) 1989-12-29
US4617306A (en) 1986-10-14
DK165965C (da) 1993-07-26
NZ207917A (en) 1988-05-30
PT78455B (en) 1986-05-27
PH20922A (en) 1987-06-05
GB8410363D0 (en) 1984-05-31
HU192050B (en) 1987-05-28
DK165965B (da) 1993-02-22
GR81973B (en]) 1984-12-12
SG53889G (en) 1989-12-08
MY100397A (en) 1990-09-17

Similar Documents

Publication Publication Date Title
EP1485094B1 (de) Oral zu applizierende darreichungsform für 3- [(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] -propionsäure-ethylester oder dessen salze
DE3877492T2 (de) Pharmazeutisches praeparat mit verzoegerter abgabe eines dihydropyridins und eines beta-adrenorezeptor-antagonisten und herstellungsverfahren dessen.
DE1643262C3 (de) i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
SK74095A3 (en) Pharmaceutical mixture with antidepressive activity
DD272035A5 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung, insbesondere einer kombination von angiotensin-converting-enzyme-hemmern mit calziumantagonisten
DD272998A5 (de) Verfahren zur herstellung von neuen arzneimitteln mit modifizierter wirkstoffabgabe in form von kuegelchen
AT393625B (de) Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten
DE69908421T2 (de) Pharmazeutische zusammensetzung enthaltend eine kombination der dextro- und laevo-isomeren von sotalol
EP0306846A2 (de) Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
BG105807A (bg) Състави с контролирано освобождаване на бетахистин
DE69807745T2 (de) Monoargininylsalz der (e)-3-[1-n-butyl-5-[(2-(2-carboxyphenyl)methoxy-4-chlorphenyl]-1h-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-en carbonsäure
DE602004010837T2 (de) Pharmazeutische zusammensetzung auf basis eines idazoxan-salzes oder eines seiner polymorphen
DE60312642T2 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
WO2011000518A1 (en) Pharmaceutical composition comprising desloratadine
DE3413955C2 (en])
SK11695A3 (en) Use of 3-benzoyl-3,7-diazobicyclo£3,3,1| nonane compounds as antiarhytmic effective medicament and method of its production
KR102720987B1 (ko) 퀴놀린 유도체 또는 그의 염을 포함하는 약학적 조성물
DE2605243A1 (de) Pyrazolessigsaeurehaltiges arzneimittel
DE3787319T2 (de) 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
AT397343B (de) Pharmazeutisches kombinationspräparat mit einem calcium-antagonisten und einem ace-hemmer
DE60028955T2 (de) R-hydroxynefazodon
EP1685828A1 (de) Feste pharmazeutische Zusammensetzung enthaltend Tilidinhydrochlorid
NZ239308A (en) Process for producing solid oral dosage forms of loperamide and dosage forms thus formed
DE3504458A1 (de) Pharmazeutisches praeparat enthaltend hydrierte ergotalkaloide und salidiuretika
DE2136929A1 (de) Cholesterinsenkende mittel

Legal Events

Date Code Title Description
SZA Application filed for a certificate of protection

Free format text: SZ90/94, 941219

EFA Change in the company name
EZF Grant of a certificate of protection

Free format text: SZ 90/1994, 19941219, EXPIRES:20100820

ELA Expired due to lapse of time